OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in treatment of ulcerative colitis with herbs: From bench to bedside
Ping Wan
World Journal of Gastroenterology (2014) Vol. 20, Iss. 39, pp. 14099-14099
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Cellular and molecular mechanisms of curcumin in prevention and treatment of disease
Sita Sharan Patel, Ashish Acharya, R. S. Ray, et al.
Critical Reviews in Food Science and Nutrition (2019) Vol. 60, Iss. 6, pp. 887-939
Closed Access | Times Cited: 378

Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats
Bolin Li, Pengli Du, Yao Du, et al.
Life Sciences (2021) Vol. 269, pp. 119008-119008
Open Access | Times Cited: 161

Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway
Taoxiu Xiong, Xiang Zheng, Ke Zhang, et al.
Journal of Ethnopharmacology (2022) Vol. 289, pp. 115001-115001
Open Access | Times Cited: 70

Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage
Daniela Catanzaro, Serena Rancan, Genny Orso, et al.
PLoS ONE (2015) Vol. 10, Iss. 5, pp. e0125375-e0125375
Open Access | Times Cited: 118

Chinese Medicine in the Treatment of Ulcerative Colitis: The Mechanisms of Signaling Pathway Regulations
Shihao Zheng, Tianyu Xue, Bin Wang, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 07, pp. 1781-1798
Closed Access | Times Cited: 66

Natural compounds as safe therapeutic options for ulcerative colitis
Mukta Gupta, Vijay Mishra, Monica Gulati, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 397-434
Open Access | Times Cited: 54

Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier
Xinhui Zhang, Fan Zhang, Yan Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12

Progress in active compounds effective on ulcerative colitis from Chinese medicines
Siyu Cao, Shengjie Ye, Weiwei Wang, et al.
Chinese Journal of Natural Medicines (2019) Vol. 17, Iss. 2, pp. 81-102
Closed Access | Times Cited: 67

Oral Colon-Targeted Konjac Glucomannan Hydrogel Constructed through Noncovalent Cross-Linking by Cucurbit[8]uril for Ulcerative Colitis Therapy
Yuan‐Fu Ding, Tianlei Sun, Shengke Li, et al.
ACS Applied Bio Materials (2019) Vol. 3, Iss. 1, pp. 10-19
Closed Access | Times Cited: 65

Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota
Zhongmei Sun, Junxiang Li, Yi Dai, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 58

Matrine protects against DSS-induced murine colitis by improving gut barrier integrity, inhibiting the PPAR-α signaling pathway, and modulating gut microbiota
Huixiang Yao, Yan Shi, Junqing Yuan, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108091-108091
Closed Access | Times Cited: 44

Natural Products Modulate Cell Apoptosis: A Promising Way for the Treatment of Ulcerative Colitis
Chenhao Liu, Yiwei Zeng, Yulong Wen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37

Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study
Mostafa M. Bahaa, Sahar K. Hegazy, M Maher, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3247-3258
Closed Access | Times Cited: 6

Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in anin vivomodel
Chiara Dianzani, Federica Foglietta, Benedetta Ferrara, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 23, pp. 4200-4200
Open Access | Times Cited: 55

Dihydrotanshinone I, a natural product, ameliorates DSS-induced experimental ulcerative colitis in mice
Yanling Guo, Xiaxia Wu, Qin Wu, et al.
Toxicology and Applied Pharmacology (2018) Vol. 344, pp. 35-45
Closed Access | Times Cited: 55

A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease
Lin Yang, Hua Luo, Dechao Tan, et al.
Phytomedicine (2021) Vol. 92, pp. 153709-153709
Closed Access | Times Cited: 39

Therapeutic Promises of Medicinal Plants in Bangladesh and Their Bioactive Compounds against Ulcers and Inflammatory Diseases
Sheikh Rashel Ahmed, Muhammad Fazle Rabbee, Anindita Roy, et al.
Plants (2021) Vol. 10, Iss. 7, pp. 1348-1348
Open Access | Times Cited: 37

Herbal bioactives in treatment of inflammation: An overview
Mukta Gupta, Naresh Singh, Monica Gulati, et al.
South African Journal of Botany (2021) Vol. 143, pp. 205-225
Open Access | Times Cited: 37

Application of network pharmacology in traditional Chinese medicine for the treatment of digestive system diseases
Shihao Zheng, Yijun Liang, Tianyu Xue, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5

Ethanolic Garcinia mangostana extract and α-mangostin improve dextran sulfate sodium-induced ulcerative colitis via the suppression of inflammatory and oxidative responses in ICR mice
Nitima Tatiya-aphiradee, Waranya Chatuphonprasert, Kanokwan Jarukamjorn
Journal of Ethnopharmacology (2020) Vol. 265, pp. 113384-113384
Closed Access | Times Cited: 35

Neuroendocrine–Immune Regulatory Network of Eucommia ulmoides Oliver
Yi Zhao, Dechao Tan, Bo Peng, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3697-3697
Open Access | Times Cited: 19

Marine sponge-derived alkaloid ameliorates DSS-induced IBD via inhibiting IL-6 expression through modulating JAK2-STAT3-SOCS3 pathway
Jing Xu, Wen-Rui Peng, Die Zhang, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111576-111576
Open Access | Times Cited: 4

Protect Effects of Perilla Seed Extract and Its Active Ingredient Luteolin Against Inflammatory Bowel Disease Model via the PI3K/AKT Signal Pathway In Vivo and In Vitro
Jin Zhang, Linlu Zhao, Jieyi He, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3564-3564
Open Access

Page 1 - Next Page

Scroll to top